博迈科(603727) - 2025 Q3 - 季度财报

Financial Performance - Revenue for Q3 2025 was CNY 279,764,555.90, a decrease of 59.91% compared to the same period last year[6] - Total profit for Q3 2025 was CNY 8,831,670.61, down 71.98% year-on-year[6] - Net profit attributable to shareholders for Q3 2025 was CNY 11,023,810.84, a decline of 64.75% compared to the previous year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2025 was CNY 8,513,704.74, down 68.48% year-on-year[6] - Basic earnings per share for Q3 2025 were CNY 0.0397, a decrease of 64.74% compared to the same period last year[7] - Total revenue for the first three quarters of 2025 was RMB 1,322,705,069.34, a decrease of 24.8% compared to RMB 1,758,401,959.76 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was RMB 23,409,706.96, a decline of 75.8% compared to RMB 94,518,608.83 in 2024[20] - Basic earnings per share for the first three quarters of 2025 were RMB 0.08, down from RMB 0.34 in the same period of 2024[20] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,450,363,766.03, a decrease of 18.06% from the end of the previous year[7] - Total assets as of September 30, 2025, were RMB 4,450,363,766.03, a decrease from RMB 5,431,539,736.87 at the end of 2024[17] - Total liabilities as of September 30, 2025, were RMB 1,273,321,266.65, down from RMB 2,208,444,419.20 at the end of 2024[17] - Cash and cash equivalents as of September 30, 2025, were RMB 797,540,327.82, compared to RMB 833,319,557.86 at the end of 2024[16] - Inventory as of September 30, 2025, increased to RMB 266,155,987.50 from RMB 232,029,415.95 at the end of 2024[16] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 53,940,904.41, with an increase attributed to tax refunds received[10] - Cash inflow from operating activities totaled approximately $1.72 billion, an increase from $1.20 billion in the previous period, reflecting a growth of about 43.7%[24] - Net cash flow from operating activities improved to approximately $53.94 million, compared to a negative cash flow of $33.83 million in the prior period[24] - Cash inflow from investment activities reached approximately $1.46 billion, significantly up from $7.03 million, indicating a substantial increase in investment recovery[24] - Net cash flow from investment activities was approximately $571.72 million, a recovery from a negative cash flow of $454.96 million in the previous period[24] - Cash inflow from financing activities was approximately $212.84 million, down from $698 million, showing a decrease of about 69.5%[24] - Net cash flow from financing activities decreased to approximately -$656.87 million, compared to -$185.08 million in the prior period[24] - The ending cash and cash equivalents balance was approximately $797.54 million, down from $1.31 billion, reflecting a decrease of about 39%[24] Research and Development - The company reported a significant increase in research and development expenses, totaling RMB 64,197,495.81 for the first three quarters of 2025, compared to RMB 91,537,533.82 in 2024[19] Non-recurring Items - Non-recurring gains and losses totaled CNY 2,510,106.10 for the current period[9] Shareholder Information - The company has not identified any related party transactions among the top ten shareholders[13]